DK2993183T3 - Anti-hpv e7-antistoffer - Google Patents

Anti-hpv e7-antistoffer Download PDF

Info

Publication number
DK2993183T3
DK2993183T3 DK15182048.7T DK15182048T DK2993183T3 DK 2993183 T3 DK2993183 T3 DK 2993183T3 DK 15182048 T DK15182048 T DK 15182048T DK 2993183 T3 DK2993183 T3 DK 2993183T3
Authority
DK
Denmark
Prior art keywords
hpv
antibodies
Prior art date
Application number
DK15182048.7T
Other languages
English (en)
Inventor
Pidder Jansen-Dürr
Werner Zwerschke
Haymo Pircher
Daniela Ehehalt
Barbara Lener
Dreier Kerstin
Original Assignee
Oesterreichische Akademie Der Wss
Austria Wirtsch Gesellschaft Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10001569A external-priority patent/EP2357197A1/en
Application filed by Oesterreichische Akademie Der Wss, Austria Wirtsch Gesellschaft Mbh filed Critical Oesterreichische Akademie Der Wss
Application granted granted Critical
Publication of DK2993183T3 publication Critical patent/DK2993183T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses
    • G01N2333/025Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/10Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK15182048.7T 2010-02-16 2011-02-16 Anti-hpv e7-antistoffer DK2993183T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10001569A EP2357197A1 (en) 2010-02-16 2010-02-16 Anti-HPV E7 antibodies
EP10011978 2010-09-30
EP11704189.7A EP2536758B1 (en) 2010-02-16 2011-02-16 Anti-hpv e7 antibodies

Publications (1)

Publication Number Publication Date
DK2993183T3 true DK2993183T3 (da) 2020-03-30

Family

ID=43919806

Family Applications (2)

Application Number Title Priority Date Filing Date
DK11704189.7T DK2536758T3 (da) 2010-02-16 2011-02-16 Anti-hpv e7-antistoffer
DK15182048.7T DK2993183T3 (da) 2010-02-16 2011-02-16 Anti-hpv e7-antistoffer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK11704189.7T DK2536758T3 (da) 2010-02-16 2011-02-16 Anti-hpv e7-antistoffer

Country Status (6)

Country Link
US (2) US9249212B2 (da)
EP (2) EP2536758B1 (da)
CA (2) CA3012796C (da)
DK (2) DK2536758T3 (da)
ES (2) ES2778654T3 (da)
WO (1) WO2011101122A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2567972A1 (en) 2011-09-12 2013-03-13 Adriacell S.p.A. Antibodies against E7 protein of Human Papilloma Virus (HPV)
WO2013038016A2 (en) * 2011-09-16 2013-03-21 Fujirebio Diagnostics Ab Monoclonal antibodies for detection of high-risk human papillomavirus oncoprotein e7
CN105175537B (zh) * 2012-06-08 2019-03-05 厦门大学 抗hpv l1蛋白的广谱单克隆抗体或其抗原结合片段及它们的用途
EP3104849B1 (en) 2014-02-14 2019-08-28 BioVentures, LLC Acetaminophen protein adducts and methods of use thereof
CN105316361B (zh) * 2014-08-01 2017-11-28 广东拓谱康生物科技有限公司 携带人乳头瘤病毒16型突变型E7m58抗原基因的重组腺相关病毒载体及其构建方法与应用
CN105504049B (zh) * 2014-09-26 2019-07-05 艾托金生物医药(苏州)有限公司 宫颈癌相关的hpv e7蛋白单克隆抗体及其应用
EP3015863A1 (en) * 2014-10-31 2016-05-04 Mikrogen GmbH Immunological test for the detection of E7 oncoproteins in biological samples
EP3227681B1 (en) 2014-12-03 2020-10-21 Bioventures, LLC Anti-acetaminophen antibodies and acetaminophen protein adducts
CN105131113B (zh) * 2015-08-26 2019-09-06 艾托金生物医药(苏州)有限公司 用于宫颈癌检测和分级的单隆抗体及其应用
CN106610378A (zh) * 2016-02-26 2017-05-03 弗雷米德生物医药技术(天津)有限公司 一种hpv16型e7蛋白的检测试剂盒
US10191046B2 (en) * 2016-05-23 2019-01-29 Se-Hwan Paek Immunobiosensor and sensor system including the same
CN107556379B (zh) * 2016-07-01 2021-05-28 艾托金生物医药(苏州)有限公司 识别高危hpv e7蛋白的单克隆抗体及其应用
MX2019003768A (es) 2016-10-03 2019-06-24 Juno Therapeutics Inc Moleculas de enlace especificas de hpv.
US20190112673A1 (en) 2017-05-10 2019-04-18 Genomic Vision Association between integration of high-risk hpv genomes detected by molecular combing and the severity and/or clinical outcome of cervical lesions
MX2020003536A (es) 2017-10-03 2020-09-14 Juno Therapeutics Inc Moleculas de union especifica a virus de papiloma humano (hpv).
MA52193A (fr) 2018-04-05 2021-02-17 Juno Therapeutics Inc Récepteurs de lymphocytes t et cellules modifiées les exprimant
WO2020109866A1 (en) 2018-11-30 2020-06-04 Genomic Vision Association between integration of viral as hpv or hiv genomes and the severity and/or clinical outcome of disorders as hpv associated cervical lesions or aids pathology
CN114276439B (zh) * 2021-11-03 2023-10-24 源道隆(苏州)医学科技有限公司 可结合人乳头瘤病毒的抗体50a11及其应用
CN114935649B (zh) * 2022-06-15 2023-07-25 广东赛尔生物科技有限公司 一种hpv病毒检测试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794371B1 (fr) * 1999-10-07 2004-06-18 Biovector Therapeutics Fragments proteiquespolyepitopiques, leur obtention et leurs utilisations notamment en vaccination
US7026443B1 (en) * 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
WO2005026731A1 (en) * 2003-09-17 2005-03-24 Amynon Biotech Gmbh Combination of anti-hpv-16 and 18 antibodies and uses thereof
US20070037180A1 (en) * 2005-02-10 2007-02-15 Olle Nilsson Site-specific immunization in order to establish antibodies with specificity for the E7 oncoprotein of high-risk HPV's
US7732166B2 (en) 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer

Also Published As

Publication number Publication date
EP2536758A1 (en) 2012-12-26
US20130029322A1 (en) 2013-01-31
US9902763B2 (en) 2018-02-27
CA2788006A1 (en) 2011-08-25
US20160237143A1 (en) 2016-08-18
WO2011101122A1 (en) 2011-08-25
CA3012796A1 (en) 2011-08-25
CA2788006C (en) 2021-08-31
EP2993183A1 (en) 2016-03-09
ES2712892T3 (es) 2019-05-16
ES2778654T3 (es) 2020-08-11
EP2536758B1 (en) 2019-01-02
US9249212B2 (en) 2016-02-02
CA3012796C (en) 2021-08-31
EP2993183B1 (en) 2020-02-26
DK2536758T3 (da) 2019-03-04

Similar Documents

Publication Publication Date Title
FR23C1023I2 (fr) Anticorps anti-il-36r
LTC2635601I2 (lt) Antikūnai prieš il-23
DK2993183T3 (da) Anti-hpv e7-antistoffer
CY2017025I2 (el) Αντιδοτα αντιπηκτικων
BR112012030311A2 (pt) anticorpo
CO6811812A2 (es) Anticuerpo anti-b7-h3
DK3178851T3 (da) Anti-cd40-antistoffer
DK3284754T3 (da) Anti-cd38-antistoffer
BR112012028556A2 (pt) Indóis
DE102011100241A8 (de) Nitridhalbleiterbauteil
CR20130111A (es) Triazina-oxidiazoles
DE10170954T8 (de) Mikrowellendruckgarer
BR112013011934A2 (pt) configuração subframe
CR20130228A (es) Anticuerpos neutralizadores anti-ccl20
CR20140127A (es) Anticuerpo anti-abtcr
CO6791565A2 (es) Anticuerpos anti-notch1
DE112011104226A5 (de) Käfigmutter
DK3351255T3 (da) Modificerede anti-cd4-antistoffer
DK3202789T3 (da) Anti-vla-4-antistoffer
DE102011117046A8 (de) Doppelkupplungswindungsgetriebe
DE112011102774A5 (de) Antriebsstrang
DE112011101226A5 (de) Linearwegmesssystem
DE112011102080A5 (de) Kupplungszentralausrücker
DE102011002623A8 (de) Ventilsteuerzeitversteller
FR2962044B1 (fr) Emulsion lacrymimetique